Subcutaneous drugs are injected in the layer of the skin called the cutis, which comprises the epidermis and dermis. The subcutaneous parenteral route of drug delivery is effective for administrating vaccines and for sustained release drugs and for insulin, goserelin etc. Numerous pharmaceutical products are marketed and being developed for various diseases which are administered through subcutaneous routes.
Drug manufacturers are also majorly focusing on packaging and effective delivery options for easy administration processes so that the drug can be introduced to the patient with reliability. As many pharmaceutical companies are developing self-administered drugs, several subcutaneous drug delivery devices have witnessed a high adoption rate.
Due to these findings, major opportunities now exist for innovative approaches to subcutaneous drug delivery devices for many leading players in the subcutaneous drug delivery market. The subcutaneous drug delivery market is growing as various advanced drug delivery devices are introduced in the market such as Jet injectors, Auto injectors, Mechanical pumps etc. Subcutaneous drug delivery systems are broadly used by end users due to the easy and reliable operating mechanism, thus generating large revenues in the subcutaneous drug delivery market.
On the other hand, the subcutaneous drug delivery market is gaining profit as conventional intravenous drugs are being replaced by subcutaneous drugs. The rapid technological advancement in subcutaneous injectable devices is attributed due to wearable patch pumps and wearable smart patch as they are prefilled and have thin needles, accommodates high dose volumes and are flexible to use. The global subcutaneous drug delivery market is expected to witness significant growth over the forecast period due to the rising prevalence of diabetes across the globe.
As per WHO 422 million of the adult population have diabetes in the US which represents a significant population and with an increasing diagnosis rate subcutaneous drug delivery market is further expected to witness growth. Increasing treatment seeking rate and spreading awareness about possible treatment options for diabetes is expected to fuel the subcutaneous drug delivery market.
Due to self-administered drugs, the administration of injectables moves increasingly from practitioner offices and healthcare facilities to patient homes.
As the subcutaneous route of administration is an effective alternative to the intravenous route of administration it is expected to future drive the growth of the subcutaneous drug delivery market. With the advent of single injector devices, auto-injectors, mechanical pumps and progress in digital medicine, it is anticipated growth in the subcutaneous drug delivery market.
Also, technical advancements like Bluetooth connectivity of glucometers also digital displays and touchscreen features in devices are expected to boost the demand for subcutaneous drug delivery technology market during the forecast period. Whereas, the high cost of these devices may hamper the growth Subcutaneous Drug Delivery market.
Many biological drugs such as monoclonal antibodies, protein-based therapeutics are under clinical trials and the subcutaneous route of administration is being investigated for their administration this is expected to contribute significantly to the Subcutaneous Drug Delivery market growth. Based on product type, fillable injectors register the highest revenue share in the subcutaneous drug delivery market owing to their reusability coupled with their less price and growing demand from patients.
As high demands for the combination of innovative drug-device products such as Insulin pumps and Omnipod for insulin from diabetic patients have contributed majorly to the growth of the market. Owing to this players are exploring new possibilities for developments in drug formulations and delivery device technology for subcutaneous drug delivery. The growing adoption rate of this subcutaneous drug delivery system is expected to fuel the demand for the subcutaneous drug delivery market.
On the basis of geography, global paraffin physical therapy market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is projected to hold largest shares in the global subcutaneous drug delivery market due to presence of leading manufacturer and advanced healthcare infrastructure. North America is the most lucrative Subcutaneous Drug Delivery market. Europe is expected to be second most lucrative Subcutaneous Drug Delivery market due to higher treatment seeking rate.
Asia-Pacific is regarded as emerging Subcutaneous Drug Delivery market due emerging economies such as India and China coupled with improving awareness among general population about treatment options. Latin America remains least lucrative Subcutaneous Drug Delivery market due to lowest adoption of Subcutaneous Drug Delivery as a treatment option.
Some of the global key participants operating in subcutaneous drug delivery market are: Insulet Corporation, Becton Dickinson Company, Consort Medical, West pharmaceuticals services Inc., Ypsomed AG, Elcam Medical, Sc Pharmaceuticals Inc., Steady Med Ltd, Amgen Inc., Sensile medical AG and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Global Subcutaneous Drug Delivery market can be segmented on the basis of Product type, Usability, Technology and Distribution channel.
Based on the Product type Subcutaneous Drug Delivery market is segmented as
Based on the usability type Subcutaneous Drug Delivery market is segmented as:
Based on the Technology type Subcutaneous Drug Delivery market is segmented as:
Based on the Distribution Channel Subcutaneous Drug Delivery market is segmented as:
Explore Similar Insights
Subcutaneous Drug Delivery Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
